APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Antiviral Drug Packaging

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Antiviral Drug Packaging Market Outlook and Growth Opportunities 2026

Report ID 173928840426 December 2025192 pages

Choose your research edition.

Industry ResearchAntiviral Drug Packaging Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Antiviral Drug Packaging Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Antiviral Drug Packaging Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antiviral Drug Packaging Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Antiviral Drug Packaging Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Antiviral Drug Packaging market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Antiviral Drug Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antiviral Drug Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antiviral Drug Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Antiviral Drug Packaging market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Antiviral Drug Packaging market include Avery Dennison Corporation, E.I. du Pont de Nemours, CCL Industries Inc, BioCote, Avient, Mondi, Biomaster, BASF and Lonza, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antiviral Drug Packaging market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antiviral Drug Packaging and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antiviral Drug Packaging sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antiviral Drug Packaging market size, projected growth trends, production technologies, key applications, and end-use industries.

Antiviral Drug Packaging Segment by Company

Avery Dennison Corporation

E.I. du Pont de Nemours

CCL Industries Inc

BioCote

Avient

Mondi

Biomaster

BASF

Lonza

Takex Labo Co. Ltd

Berry

Lageen Tubes.

Antiviral Drug Packaging Segment by Type

Rigid Plastic

Flexible Blister Foils

Others

Antiviral Drug Packaging Segment by Application

Pharmaceuticals

Healthcare

Antiviral Drug Packaging Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Antiviral Drug Packaging status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Antiviral Drug Packaging market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Antiviral Drug Packaging significant trends, drivers, influence factors in global and regions.

6. To analyze Antiviral Drug Packaging competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiviral Drug Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antiviral Drug Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiviral Drug Packaging.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antiviral Drug Packaging market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antiviral Drug Packaging industry.

Chapter 3: Detailed analysis of Antiviral Drug Packaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Antiviral Drug Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Antiviral Drug Packaging in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Antiviral Drug Packaging Industry Trends Table 2. Antiviral Drug Packaging Industry Drivers Table 3. Antiviral Drug Packaging Industry Opportunities and Challenges Table 4. Antiviral Drug Packaging Industry Restraints Table 5. Global Antiviral Drug Packaging Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Antiviral Drug Packaging Revenue Share by Company (2021-2026) Table 7. Global Antiviral Drug Packaging Sales Volume by Company (k units) & (2021-2026) Table 8. Global Antiviral Drug Packaging Sales Volume Share by Company (2021-2026) Table 9. Global Antiviral Drug Packaging Average Price (USD/unit) of Company (2021-2026) Table 10. Global Antiviral Drug Packaging Company Ranking, (2024-2026) & (USD Million) Table 11. Global Antiviral Drug Packaging Key Company Manufacturing Base & Headquarters Table 12. Global Antiviral Drug Packaging Company, Product Type & Application Table 13. Global Antiviral Drug Packaging Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Antiviral Drug Packaging by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Rigid Plastic Table 18. Significant Companies of Flexible Blister Foils Table 19. Significant Companies of Others Table 20. Global Antiviral Drug Packaging Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Antiviral Drug Packaging Sales Volume by Type (2021-2026) & (k units) Table 22. Global Antiviral Drug Packaging Sales Volume by Type (2027-2032) & (k units) Table 23. Global Antiviral Drug Packaging Sales Volume Share by Type (2021-2026) Table 24. Global Antiviral Drug Packaging Sales Volume Share by Type (2027-2032) Table 25. Global Antiviral Drug Packaging Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Antiviral Drug Packaging Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Antiviral Drug Packaging Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Antiviral Drug Packaging Sales Value Share by Type (2021-2026) Table 29. Global Antiviral Drug Packaging Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Pharmaceuticals Table 31. Significant Companies of Healthcare Table 32. Global Antiviral Drug Packaging Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Antiviral Drug Packaging Sales Volume by Application (2021-2026) & (k units) Table 34. Global Antiviral Drug Packaging Sales Volume by Application (2027-2032) & (k units) Table 35. Global Antiviral Drug Packaging Sales Volume Share by Application (2021-2026) Table 36. Global Antiviral Drug Packaging Sales Volume Share by Application (2027-2032) Table 37. Global Antiviral Drug Packaging Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Antiviral Drug Packaging Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Antiviral Drug Packaging Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Antiviral Drug Packaging Sales Value Share by Application (2021-2026) Table 41. Global Antiviral Drug Packaging Sales Value Share by Application (2027-2032) Table 42. Global Antiviral Drug Packaging Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Antiviral Drug Packaging Sales by Region (2021-2026) & (k units) Table 44. Global Antiviral Drug Packaging Sales Market Share by Region (2021-2026) Table 45. Global Antiviral Drug Packaging Sales by Region (2027-2032) & (k units) Table 46. Global Antiviral Drug Packaging Sales Market Share by Region (2027-2032) Table 47. Global Antiviral Drug Packaging Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Antiviral Drug Packaging Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Antiviral Drug Packaging Sales Value Share by Region (2021-2026) Table 50. Global Antiviral Drug Packaging Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Antiviral Drug Packaging Sales Value Share by Region (2027-2032) Table 52. Global Antiviral Drug Packaging Market Average Price (USD/unit) by Region (2021-2026) Table 53. Global Antiviral Drug Packaging Market Average Price (USD/unit) by Region (2027-2032) Table 54. Global Antiviral Drug Packaging Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Antiviral Drug Packaging Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Antiviral Drug Packaging Sales by Country (2021-2026) & (k units) Table 57. Global Antiviral Drug Packaging Sales Market Share by Country (2021-2026) Table 58. Global Antiviral Drug Packaging Sales by Country (2027-2032) & (k units) Table 59. Global Antiviral Drug Packaging Sales Market Share by Country (2027-2032) Table 60. Global Antiviral Drug Packaging Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Antiviral Drug Packaging Sales Value Market Share by Country (2021-2026) Table 62. Global Antiviral Drug Packaging Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Antiviral Drug Packaging Sales Value Market Share by Country (2027-2032) Table 64. Avery Dennison Corporation Company Information Table 65. Avery Dennison Corporation Business Overview Table 66. Avery Dennison Corporation Antiviral Drug Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 67. Avery Dennison Corporation Antiviral Drug Packaging Product Portfolio Table 68. Avery Dennison Corporation Recent Development Table 69. E.I. du Pont de Nemours Company Information Table 70. E.I. du Pont de Nemours Business Overview Table 71. E.I. du Pont de Nemours Antiviral Drug Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. E.I. du Pont de Nemours Antiviral Drug Packaging Product Portfolio Table 73. E.I. du Pont de Nemours Recent Development Table 74. CCL Industries Inc Company Information Table 75. CCL Industries Inc Business Overview Table 76. CCL Industries Inc Antiviral Drug Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. CCL Industries Inc Antiviral Drug Packaging Product Portfolio Table 78. CCL Industries Inc Recent Development Table 79. BioCote Company Information Table 80. BioCote Business Overview Table 81. BioCote Antiviral Drug Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. BioCote Antiviral Drug Packaging Product Portfolio Table 83. BioCote Recent Development Table 84. Avient Company Information Table 85. Avient Business Overview Table 86. Avient Antiviral Drug Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Avient Antiviral Drug Packaging Product Portfolio Table 88. Avient Recent Development Table 89. Mondi Company Information Table 90. Mondi Business Overview Table 91. Mondi Antiviral Drug Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Mondi Antiviral Drug Packaging Product Portfolio Table 93. Mondi Recent Development Table 94. Biomaster Company Information Table 95. Biomaster Business Overview Table 96. Biomaster Antiviral Drug Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Biomaster Antiviral Drug Packaging Product Portfolio Table 98. Biomaster Recent Development Table 99. BASF Company Information Table 100. BASF Business Overview Table 101. BASF Antiviral Drug Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. BASF Antiviral Drug Packaging Product Portfolio Table 103. BASF Recent Development Table 104. Lonza Company Information Table 105. Lonza Business Overview Table 106. Lonza Antiviral Drug Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Lonza Antiviral Drug Packaging Product Portfolio Table 108. Lonza Recent Development Table 109. Takex Labo Co. Ltd Company Information Table 110. Takex Labo Co. Ltd Business Overview Table 111. Takex Labo Co. Ltd Antiviral Drug Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Takex Labo Co. Ltd Antiviral Drug Packaging Product Portfolio Table 113. Takex Labo Co. Ltd Recent Development Table 114. Berry Company Information Table 115. Berry Business Overview Table 116. Berry Antiviral Drug Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Berry Antiviral Drug Packaging Product Portfolio Table 118. Berry Recent Development Table 119. Lageen Tubes. Company Information Table 120. Lageen Tubes. Business Overview Table 121. Lageen Tubes. Antiviral Drug Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Lageen Tubes. Antiviral Drug Packaging Product Portfolio Table 123. Lageen Tubes. Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Antiviral Drug Packaging Distributors List Table 127. Antiviral Drug Packaging Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Antiviral Drug Packaging Product Image Figure 2. Global Antiviral Drug Packaging Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antiviral Drug Packaging Sales Value (2021-2032) & (US$ Million) Figure 4. Global Antiviral Drug Packaging Sales (2021-2032) & (k units) Figure 5. Global Antiviral Drug Packaging Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Antiviral Drug Packaging Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Rigid Plastic Image Figure 10. Flexible Blister Foils Image Figure 11. Others Image Figure 12. Global Antiviral Drug Packaging Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Antiviral Drug Packaging Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Antiviral Drug Packaging Sales Volume Share by Type (2021-2032) Figure 15. Global Antiviral Drug Packaging Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Antiviral Drug Packaging Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Antiviral Drug Packaging Sales Value Share by Type (2021-2032) Figure 18. Pharmaceuticals Image Figure 19. Healthcare Image Figure 20. Global Antiviral Drug Packaging Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Antiviral Drug Packaging Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Antiviral Drug Packaging Sales Volume Share by Application (2021-2032) Figure 23. Global Antiviral Drug Packaging Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Antiviral Drug Packaging Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Antiviral Drug Packaging Sales Value Share by Application (2021-2032) Figure 26. Global Antiviral Drug Packaging Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Antiviral Drug Packaging Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Antiviral Drug Packaging Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Antiviral Drug Packaging Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Antiviral Drug Packaging Sales Value (2021-2032) & (US$ Million) Figure 31. North America Antiviral Drug Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Antiviral Drug Packaging Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Antiviral Drug Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Antiviral Drug Packaging Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Antiviral Drug Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Antiviral Drug Packaging Sales Value (2021-2032) & (US$ Million) Figure 37. South America Antiviral Drug Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Antiviral Drug Packaging Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Antiviral Drug Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Antiviral Drug Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Antiviral Drug Packaging Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Antiviral Drug Packaging Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Rigid Plastic
  • Flexible Blister Foils
  • Others
Applications
  • Pharmaceuticals
  • Healthcare
Companies covered
  • Avery Dennison Corporation
  • E.I. du Pont de Nemours
  • CCL Industries Inc
  • BioCote
  • Avient
  • Mondi
  • Biomaster
  • BASF
  • Lonza
  • Takex Labo Co. Ltd
  • Berry
  • Lageen Tubes.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antiviral Drug Packaging Sales Value (2021-2032)
  4. 1.2.2 Global Antiviral Drug Packaging Sales Volume (2021-2032)
  5. 1.2.3 Global Antiviral Drug Packaging Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Antiviral Drug Packaging Market Dynamics
  1. 2.1 Antiviral Drug Packaging Industry Trends
  2. 2.2 Antiviral Drug Packaging Industry Drivers
  3. 2.3 Antiviral Drug Packaging Industry Opportunities and Challenges
  4. 2.4 Antiviral Drug Packaging Industry Restraints
3 Antiviral Drug Packaging Market by Company
  1. 3.1 Global Antiviral Drug Packaging Company Revenue Ranking in 2025
  2. 3.2 Global Antiviral Drug Packaging Revenue by Company (2021-2026)
  3. 3.3 Global Antiviral Drug Packaging Sales Volume by Company (2021-2026)
  4. 3.4 Global Antiviral Drug Packaging Average Price by Company (2021-2026)
  5. 3.5 Global Antiviral Drug Packaging Company Ranking (2024-2026)
  6. 3.6 Global Antiviral Drug Packaging Company Manufacturing Base and Headquarters
  7. 3.7 Global Antiviral Drug Packaging Company Product Type and Application
  8. 3.8 Global Antiviral Drug Packaging Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Antiviral Drug Packaging Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Antiviral Drug Packaging Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Antiviral Drug Packaging Market by Type
  1. 4.1 Antiviral Drug Packaging Type Introduction
  2. 4.1.1 Rigid Plastic
  3. 4.1.2 Flexible Blister Foils
  4. 4.1.3 Others
  5. 4.2 Global Antiviral Drug Packaging Sales Volume by Type
  6. 4.2.1 Global Antiviral Drug Packaging Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Antiviral Drug Packaging Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Antiviral Drug Packaging Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Antiviral Drug Packaging Sales Value by Type
  10. 4.3.1 Global Antiviral Drug Packaging Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Antiviral Drug Packaging Sales Value by Type (2021-2032)
  12. 4.3.3 Global Antiviral Drug Packaging Sales Value Share by Type (2021-2032)
5 Antiviral Drug Packaging Market by Application
  1. 5.1 Antiviral Drug Packaging Application Introduction
  2. 5.1.1 Pharmaceuticals
  3. 5.1.2 Healthcare
  4. 5.2 Global Antiviral Drug Packaging Sales Volume by Application
  5. 5.2.1 Global Antiviral Drug Packaging Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Antiviral Drug Packaging Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Antiviral Drug Packaging Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Antiviral Drug Packaging Sales Value by Application
  9. 5.3.1 Global Antiviral Drug Packaging Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Antiviral Drug Packaging Sales Value by Application (2021-2032)
  11. 5.3.3 Global Antiviral Drug Packaging Sales Value Share by Application (2021-2032)
6 Antiviral Drug Packaging Regional Sales and Value Analysis
  1. 6.1 Global Antiviral Drug Packaging Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antiviral Drug Packaging Sales by Region (2021-2032)
  3. 6.2.1 Global Antiviral Drug Packaging Sales by Region: 2021-2026
  4. 6.2.2 Global Antiviral Drug Packaging Sales by Region (2027-2032)
  5. 6.3 Global Antiviral Drug Packaging Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Antiviral Drug Packaging Sales Value by Region (2021-2032)
  7. 6.4.1 Global Antiviral Drug Packaging Sales Value by Region: 2021-2026
  8. 6.4.2 Global Antiviral Drug Packaging Sales Value by Region (2027-2032)
  9. 6.5 Global Antiviral Drug Packaging Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Antiviral Drug Packaging Sales Value (2021-2032)
  12. 6.6.2 North America Antiviral Drug Packaging Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Antiviral Drug Packaging Sales Value (2021-2032)
  15. 6.7.2 Europe Antiviral Drug Packaging Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Antiviral Drug Packaging Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Antiviral Drug Packaging Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Antiviral Drug Packaging Sales Value (2021-2032)
  21. 6.9.2 South America Antiviral Drug Packaging Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Antiviral Drug Packaging Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Antiviral Drug Packaging Sales Value Share by Country, 2025 VS 2032
7 Antiviral Drug Packaging Country-level Sales and Value Analysis
  1. 7.1 Global Antiviral Drug Packaging Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Antiviral Drug Packaging Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Antiviral Drug Packaging Sales by Country (2021-2032)
  4. 7.3.1 Global Antiviral Drug Packaging Sales by Country (2021-2026)
  5. 7.3.2 Global Antiviral Drug Packaging Sales by Country (2027-2032)
  6. 7.4 Global Antiviral Drug Packaging Sales Value by Country (2021-2032)
  7. 7.4.1 Global Antiviral Drug Packaging Sales Value by Country (2021-2026)
  8. 7.4.2 Global Antiviral Drug Packaging Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Antiviral Drug Packaging Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Antiviral Drug Packaging Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Antiviral Drug Packaging Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Avery Dennison Corporation
  2. 8.1.1 Avery Dennison Corporation Company Information
  3. 8.1.2 Avery Dennison Corporation Business Overview
  4. 8.1.3 Avery Dennison Corporation Antiviral Drug Packaging Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Avery Dennison Corporation Antiviral Drug Packaging Product Portfolio
  6. 8.1.5 Avery Dennison Corporation Recent Developments
  7. 8.2 E.I. du Pont de Nemours
  8. 8.2.1 E.I. du Pont de Nemours Company Information
  9. 8.2.2 E.I. du Pont de Nemours Business Overview
  10. 8.2.3 E.I. du Pont de Nemours Antiviral Drug Packaging Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 E.I. du Pont de Nemours Antiviral Drug Packaging Product Portfolio
  12. 8.2.5 E.I. du Pont de Nemours Recent Developments
  13. 8.3 CCL Industries Inc
  14. 8.3.1 CCL Industries Inc Company Information
  15. 8.3.2 CCL Industries Inc Business Overview
  16. 8.3.3 CCL Industries Inc Antiviral Drug Packaging Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 CCL Industries Inc Antiviral Drug Packaging Product Portfolio
  18. 8.3.5 CCL Industries Inc Recent Developments
  19. 8.4 BioCote
  20. 8.4.1 BioCote Company Information
  21. 8.4.2 BioCote Business Overview
  22. 8.4.3 BioCote Antiviral Drug Packaging Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 BioCote Antiviral Drug Packaging Product Portfolio
  24. 8.4.5 BioCote Recent Developments
  25. 8.5 Avient
  26. 8.5.1 Avient Company Information
  27. 8.5.2 Avient Business Overview
  28. 8.5.3 Avient Antiviral Drug Packaging Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Avient Antiviral Drug Packaging Product Portfolio
  30. 8.5.5 Avient Recent Developments
  31. 8.6 Mondi
  32. 8.6.1 Mondi Company Information
  33. 8.6.2 Mondi Business Overview
  34. 8.6.3 Mondi Antiviral Drug Packaging Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Mondi Antiviral Drug Packaging Product Portfolio
  36. 8.6.5 Mondi Recent Developments
  37. 8.7 Biomaster
  38. 8.7.1 Biomaster Company Information
  39. 8.7.2 Biomaster Business Overview
  40. 8.7.3 Biomaster Antiviral Drug Packaging Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Biomaster Antiviral Drug Packaging Product Portfolio
  42. 8.7.5 Biomaster Recent Developments
  43. 8.8 BASF
  44. 8.8.1 BASF Company Information
  45. 8.8.2 BASF Business Overview
  46. 8.8.3 BASF Antiviral Drug Packaging Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 BASF Antiviral Drug Packaging Product Portfolio
  48. 8.8.5 BASF Recent Developments
  49. 8.9 Lonza
  50. 8.9.1 Lonza Company Information
  51. 8.9.2 Lonza Business Overview
  52. 8.9.3 Lonza Antiviral Drug Packaging Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Lonza Antiviral Drug Packaging Product Portfolio
  54. 8.9.5 Lonza Recent Developments
  55. 8.10 Takex Labo Co. Ltd
  56. 8.10.1 Takex Labo Co. Ltd Company Information
  57. 8.10.2 Takex Labo Co. Ltd Business Overview
  58. 8.10.3 Takex Labo Co. Ltd Antiviral Drug Packaging Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Takex Labo Co. Ltd Antiviral Drug Packaging Product Portfolio
  60. 8.10.5 Takex Labo Co. Ltd Recent Developments
  61. 8.11 Berry
  62. 8.11.1 Berry Company Information
  63. 8.11.2 Berry Business Overview
  64. 8.11.3 Berry Antiviral Drug Packaging Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Berry Antiviral Drug Packaging Product Portfolio
  66. 8.11.5 Berry Recent Developments
  67. 8.12 Lageen Tubes.
  68. 8.12.1 Lageen Tubes. Company Information
  69. 8.12.2 Lageen Tubes. Business Overview
  70. 8.12.3 Lageen Tubes. Antiviral Drug Packaging Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Lageen Tubes. Antiviral Drug Packaging Product Portfolio
  72. 8.12.5 Lageen Tubes. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antiviral Drug Packaging Value Chain Analysis
  2. 9.1.1 Antiviral Drug Packaging Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antiviral Drug Packaging Sales Mode & Process
  6. 9.2 Antiviral Drug Packaging Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antiviral Drug Packaging Distributors
  9. 9.2.3 Antiviral Drug Packaging Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst